An Open-Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia

Susan H. Fox, Matthew Swan, Hyder A. Jinnah, Maria E.T. de Freitas, Lais M. de Oliveira, Duha Al-Shorafat, Hubert H. Fernandez, Katie Kompoliti, Cynthia Comella

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'An Open-Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science